Although its precise mechanism of action has to be elucidated in further studies, our preliminary data show that it targets the spliceosomal complex and induces alternative splicing leading to induction of cellular stress and apoptosis also in PI-resistant MM, in particular in combination with proteasome or HDAC inhibition. This evidence concerns the gene HDAC9 and Miyoshi myopathy.